Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability

@article{ShawSmith2006MicrodeletionEM,
  title={Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability},
  author={C. Shaw-Smith and A. Pittman and L. Willatt and H. Martin and L. Rickman and S. Gribble and R. Curley and S. Cumming and C. Dunn and D. Kalaitzopoulos and K. Porter and E. Prigmore and A. C. Krepischi-Santos and M. Varela and C. Koiffmann and A. Lees and C. Rosenberg and H. Firth and R. Silva and N. Carter},
  journal={Nature Genetics},
  year={2006},
  volume={38},
  pages={1032-1037}
}
  • C. Shaw-Smith, A. Pittman, +17 authors N. Carter
  • Published 2006
  • Biology, Medicine
  • Nature Genetics
  • Recently, the application of array-based comparative genomic hybridization (array CGH) has improved rates of detection of chromosomal imbalances in individuals with mental retardation and dysmorphic features. Here, we describe three individuals with learning disability and a heterozygous deletion at chromosome 17q21.3, detected in each case by array CGH. FISH analysis demonstrated that the deletions occurred as de novo events in each individual and were between 500 kb and 650 kb in size. A… CONTINUE READING
    337 Citations
    Copy number variation at the 7q11.23 segmental duplications is a susceptibility factor for the Williams-Beuren syndrome deletion.
    • 70
    • PDF
    Resolving the breakpoints of the 17q21.31 microdeletion syndrome with next-generation sequencing.
    • 20
    Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation
    • 264
    • PDF

    References

    SHOWING 1-10 OF 29 REFERENCES
    Genomic inversions of human chromosome 15q11-q13 in mothers of Angelman syndrome patients with class II (BP2/3) deletions.
    • 138
    • PDF
    A 17q21.31 microdeletion encompassing the MAPT gene in a mentally impaired patient
    • 47
    • PDF
    Development and validation of a CGH microarray for clinical cytogenetic diagnosis
    • 242
    • PDF